title: Neurocognitive function in same-sex twins following focal radiation for medulloblastoma.
abstract: Increased neurotoxicity and poor long-term neurocognitive outcome of preschool children treated for brain tumors have led to innovative therapeutic strategies in order to delay or avoid the use of craniospinal radiation and to improve survival. Because these protocols are relatively new, few data exist regarding cognitive outcome. We conducted a twin case-control study to investigate neurocognitive and behavioral outcome in a preschool patient who was 16 months old at diagnosis of medulloblastoma and was treated with surgery, chemotherapy, stem cell transplant, and focal radiation to the tumor bed. Stability and change over two assessments were compared for the patient and her nonaffected twin for standardized measures of cognitive function and experimental measures of parent-child interaction, social competence, and goal-directed play. A striking finding was improvement in intelligence, receptive language, and visual-motor functioning in the affected twin from 12 months to 24 months after treatment. Improvement in ratings of parent-child interaction and social competence for the affected twin was also evident. These findings are notable compared with the potentially devastating impact of craniospinal tumor, and this study is among the first to document the relative benefit of focal radiation in sparing cognitive function, albeit in a single case study.
authors: Department of Psychology, Hospital for Sick Children, 555 University Ave., Toronto, ON M5G 1X8, Canada. donald.mabbott@sickkids.ca
authors: Donald J
authors: DJ
authors: Mabbott
authors: Marcia
authors: M
authors: Barnes
authors: Normand
authors: N
authors: Laperriere
authors: Susan H
authors: SH
authors: Landry
authors: Eric
authors: E
authors: Bouffet
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D002528:Cerebellar Neoplasms / Q000532:radiotherapy*; D002675:Child, Preschool; D003071:Cognition / Q000528:radiation effects*; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D008527:Medulloblastoma / Q000532:radiotherapy*; D009483:Neuropsychological Tests; D019635:Neurosurgical Procedures; D033581:Stem Cell Transplantation; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents
references: Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):137-45
references: 10477017
references: J Clin Oncol. 1999 Mar;17(3):832-45
references: 10071274
references: Lancet Oncol. 2005 Aug;6(8):573-80
references: 16054568
references: J Clin Oncol. 2005 Oct 1;23(28):7152-60
references: 16192599
references: J Clin Oncol. 1999 Nov;17(11):3476-86
references: 10550145
references: J Clin Oncol. 1999 Dec;17(12):3720-8
references: 10577843
references: Child Dev. 2000 Mar-Apr;71(2):358-75
references: 10834470
references: Pediatr Neurosurg. 2003 Jul;39(2):60-7
references: 12845195
references: Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):531-6
references: 15380589
references: Acta Radiol Ther Phys Biol. 1974 Jun;13(3):255-65
references: 4136837
references: J Clin Oncol. 1989 Nov;7(11):1660-6
references: 2809681
references: J Child Neurol. 1992 Jul;7(3):281-90
references: 1634751
references: Cancer. 1994 May 1;73(9):2450-5
references: 8168048
references: J Dev Behav Pediatr. 1994 Apr;15(2):124-30
references: 8034765
references: J Child Neurol. 1995 May;10(3):209-12
references: 7642890
references: J Neurooncol. 1997 May;32(3):243-52
references: 9049886
references: J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):125-30
references: 9544162
references: N Engl J Med. 2005 Mar 10;352(10):978-86
references: 15758008